Hims & Hers is making a major global expansion with its planned acquisition of Australian digital health company Eucalyptus, a good move for the company as it faces regulatory and

Novartis is looking to build up its cardiovascular drug pipeline and it’s now partnering with Unnatural Products to support the effort. The pharmaceutical company is committing up to $100 million

The healthcare industry is under strain. Care delivery is fragmented, and clinicians are operating in an industry where nearly half of health systems aren’t profitable. The result is a clinical

Across healthcare and life sciences, CRM migrations are accelerating. To keep up with stricter regulatory expectations, rising patient demands, technological advancement, new use cases, and the growing volume of clinical

A large, three-year clinical trial designed to demonstrate how Grail’s blood test for early cancer detection could work in a broad population has preliminary results showing reduction in late-stage cancer

With hospitals facing ongoing financial pressures, including rising costs and declining reimbursement rates, they’re looking for tools that not only improve efficiency — but also increase revenue. Mercyhealth seems to

Rainfall Health, an AI-powered compliance and reimbursement platform for hospitals and medical groups, has raised $15 million in Series A funding, it announced on Wednesday. The San Francisco-based company helps

Global life sciences giant Danaher coughed up a pretty penny to buy Masimo this week, spending roughly $10 billion to beef up its diagnostics portfolio. The deal values medical device

Frist Cressey Ventures closed a $425 million fund, which it will use to invest in early-stage healthcare companies focused on bringing down costs and leveraging AI, the firm announced on

America’s mental health crisis is often framed as a clinician shortage problem. Demand for appointments is rising faster than availability, waitlists are growing, and burnout is pushing clinicians out of